Delivery Order SPE2DB22D2206-SPE2DB24FFK96

Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $2.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $3,444.83 issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of LAMICTAL 200 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The IDC has a $999,999,999 ceiling value and runs through November 2026, serving as a primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award, with ID SPE2DX15D3013|SPE2DX24FG8D0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,267.32 firm fixed-price delivery order is for the supply of LAMICTAL ODT 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, valued at $22,501.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4562468216 LAMICTAL 25 MG DISPER TABLET 100S, with a period of performance through October 16, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,355.51 firm fixed-price delivery order is for the supply of Lamictal ODT 200 mg tablets. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lamictal 200 mg tablets. The $1,911.36 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,702.34 Firm Fixed Price Delivery Order contract covers the supply of LAMICTAL 150 MG TABLET 60S, a pharmaceutical product, with a period of performance through December 14, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,549.68 firm fixed-price delivery order is for the supply of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,493.27 firm fixed-price delivery order is for the supply of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $27,121.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the medication Lamictal XR 200 mg tablets and has a completion date of January 31, 2024. The contract is a firm fixed-price arrangement and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,052.90, is a Firm Fixed Price Delivery Order for the supply of LAMICTAL 200 MG TABLET 60S. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FFK96
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,403.92, is for the delivery of LAMICTAL ODT 200 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 5, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award demonstrates Amerisourcebergen Drug Corp's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs.

Generated 5/14/25, 10:11 AM